Rapport Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham | Chief Executive Officer | Sale | 2,147 | $28.84 | $61,919 | 33,831 | Dec 17, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 796 | $30.68 | $24,421 | 392,642 | Dec 15, 2025 |
| Gault Cheryl | Chief Operating Officer | Sale | 5,000 | $30.10 | $150,500 | 171,928 | Nov 26, 2025 |
| Ceesay Abraham | Chief Executive Officer | Sale | 2,841 | $25.44 | $72,275 | 35,978 | Nov 17, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 3,156 | $24.84 | $78,395 | 406,486 | Nov 17, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 7,418 | $25.73 | $190,865 | 410,724 | Oct 15, 2025 |
| Ceesay Abraham | Chief Executive Officer | Sale | 755 | $26.17 | $19,758 | 41,061 | Oct 15, 2025 |
| Ceesay Abraham | Chief Executive Officer | Sale | 700 | $27.04 | $18,928 | 46,144 | Sep 17, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 3,402 | $24.66 | $83,893 | 418,142 | Sep 15, 2025 |
| Huber Reid M | — | Purchase | 20,400 | $24.48 | $499,392 | 20,400 | Sep 12, 2025 |
| PAUL STEVEN M | — | Purchase | 13,382 | $24.97 | $334,149 | 41,666 | Sep 12, 2025 |
| Young Wendy B. | — | Purchase | 3,500 | $22.60 | $79,100 | 9,500 | Sep 11, 2025 |
| Gault Cheryl | Chief Operating Officer | Sale | 5,000 | $38.33 | $191,650 | 171,928 | Sep 8, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 200 | $15.79 | $3,158 | 426,642 | Aug 15, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 8,500 | $14.00 | $119,000 | 435,142 | Jul 15, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 8,500 | $11.00 | $93,500 | 443,642 | Jun 16, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 8,500 | $9.56 | $81,260 | 452,142 | May 15, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 8,500 | $9.57 | $81,345 | 460,642 | Apr 15, 2025 |
| Bredt David | Chief Scientific Officer | Sale | 8,500 | $10.85 | $92,225 | 469,142 | Mar 14, 2025 |
| Ignelzi Troy A. | Chief Financial Officer | Purchase | 100 | $9.98 | $998 | 10,000 | Mar 12, 2025 |
| Young Wendy B. | — | Purchase | 6,000 | $10.21 | $61,260 | 6,000 | Mar 12, 2025 |
| Gault Cheryl | Chief Operating Officer | Award / Grant | 13,987 | — | — | 171,928 | Mar 3, 2025 |
| HEALY JAMES | — | Purchase | 3,657 | $24.21 | $88,536 | 33,565 | Jul 1, 2024 |
| NELSEN ROBERT | — | C | 3,728,738 | — | — | 3,728,738 | Jun 10, 2024 |
| Third Rock Ventures V, L.P. | — | C | 969,218 | — | — | 969,218 | Jun 10, 2024 |
| HEALY JAMES | — | C | 1,392,738 | — | — | 1,392,738 | Jun 10, 2024 |